Tag: Serum Institute of India
Serum Institute ships first set of 43,200 malarial vaccine doses to...
The initial shipment will be sent to the Central African Republic (CAR), followed by other African countries such as South Sudan and Democratic Republic of Congo in the next coming days
Serum Institute to acquire 20% stake in IntegriMedical, India’s first needle-free...
The investment by SII in IntegriMedical is expected to accelerate the development and commercialization of the N-FIS technology, making it more widely accessible to patients in India and worldwide
CCI approves merger by absorption of Covidshield Technologies into Biocon Biologics
The target is a subsidiary of Biocon Limited, and it offers treatment for chronic and acute diseases such as diabetes, oncology, nephrology, cancer, and autoimmune diseases
Covovax to help Serum Institute to enter adolescents COVID-19 vaccine market:...
According to GlobalData’s Pharma Intelligence Center, Covovax is India's fourth COVID-19 vaccine approved for adolescents aged 12 to 18 years
Biotech stalwarts to be honored with Padma Bhushan Award
Dr Cyrus Poonawalla of Serum Institute of India; and Dr Krishna Ella and Suchitra Ella of Bharat Biotech have found their place in the just released list of Padma Awards. They will be honored with Padma Bhushan for the role played by their companies during Covid-19 pandemic
Serum Institute develops novel coronavirus vaccine candidate, human trials in 6...
Serum Institute of India-Codagenix developed novel coronavirus virus-vaccine strain is first to progress to pre-clinical testing phase. The project has been running at an estimated cost of INR 300 crores......................
SII invents the first-ever heat-stable Rotavirus vaccine in the world, Rotasiil
The company's Rotasiil is the only vaccine that remains heat-stable for up to 30 months at a temperature of 25°C. It has been granted patent by the United States Patent and Trademark Office...............
Serum Institute’s ROTASIIL shows great efficacy, included in national immunization program
The international nonprofit PATH partnered with Serum Institute of India to evaluate the vaccine which demonstrated significant efficacy against severe rotavirus gastroenteritis during its Phase 3 trials...........
Serum Institute of India buys Czech Republic’s Nanotherapeutics
This acquisition of the Czech Republic based company will add to SII group injectable Polio capacity, increasing it by 4 times to a total of 200 million doses by 2019.......
PATH welcomes new promising study results for rotavirus vaccine candidate
PATH is also working with Serum Institute to conduct an additional Phase 3 study to gather data required for World Health Organization (WHO) prequalification